Archive

Posts Tagged ‘Thomas Gazda’

Psychopharmacology

Thomas Gazda, MD, trained full-time in medicine for 10 years after he earned his bachelor’s degree. He earned his MD from the College of Medicine at the University of Illinois, followed by three years of residency in family practice and three years in psychiatry. Board-certified in psychiatry and family practice, Dr. Thomas Gazda today practices as a psychopharmacologist.

The study of the effect of drugs on thinking, sensation, behavior, and mood, psychopharmacology concentrates primarily on the chemical reactions that take place in the brain. Its practitioners frequently use various drugs to treat mental disorders. Because the body of knowledge in the field is constantly expanding, practitioners must continually stay abreast of current developments.

Psychopharmacologists work with many substances that have psychoactive properties. These include anesthetics, analgesics, and anticonvulsant drugs. Psychotropic medications are grouped into several categories according to the disorder for which they were developed; these categories include mood stabilizers, stimulants, antidepressants, antipsychotics, antianxiety and antipanic agents, and antiobsessive medications.

Psychopharmacologists must be thoroughly trained medical doctors, as they diagnose disorders and rule out physical causes for disorders. In addition, they must be knowledgeable of all the body’s systems and functions to be able to interpret and treat anticipated as well as unexpected side effects.

Dr. Thomas Gazda Discusses sanofi-aventis U.S., LLC

October 30, 2013 Leave a comment

Headquartered in Bridgewater, New Jersey, sanofi-aventis U.S., LLC, functions as the American subsidiary of the France-based Sanofi, one of the world’s largest health care companies. With facilities in over 100 countries, this pharmaceutical firm possesses a history extending back nearly three centuries.

Responsible for producing medications for humans and animals, sanofi-aventis U.S. dedicates itself to enhancing the health care industry while remaining committed to social responsibility. Its vaccines, which are developed through its Sanofi Pasteur subsidiary, treat tetanus, pertussis, polio, rabies, and other conditions. Prescription products from this business include Ambien, Carticel, Ketek, and Nasacort AQ Nasal Spray. In August 2012, sanofi-aventis U.S. announced that it garnered approval from the U.S. Food and Drug Administration for Zaltrap, a colorectal cancer medication that it co-created with Regeneron Pharmaceuticals. To read more about the company and its latest innovations, log onto Sanofi.us.

About the Author:

Operating out of Banner Behavioral Health in Scottsdale, Dr. Thomas Gazda possesses training in biological psychiatry and psychodynamic psychotherapy. Additionally, Dr. Thomas Gazda has acted as a Pharmaceutical Speaker and Consultant with sanofi-aventis U.S. since 2005.

The Research Role of the American Psychiatric Association

August 29, 2012 Leave a comment

By Thomas Gazda, M.D.

The American Psychiatric Association (APA) performs research that generates information to guide the treatment of mental and addictive disorders. APA research findings also serve as the basis for designing innovations in delivery systems and for influencing policy that affects those with mental illness, their families, service providers, insurers, and all levels of government.

In the past decade, APA research has spanned eight areas. The first important research function is to review scientific findings that present evidence for changes in diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM). This elaborate project draws upon the expertise of national and international research investigators from multiple disciplines. Similarly, the APA relies upon national and international experts for the development of practice guidelines, which assess the efficacy of treatments studied in clinical trials. In its third research function, the APA has focused on service and health policy research, such as that conducted concerning access to care and access to protected medications.

The fourth and fifth areas of research include the development of standards for quality psychiatric care as well as licensure and certification requirements. Additionally, the APA has developed a sixth area of research activity devoted to promoting research training. In order to understand changes and trends in the psychiatric workforce, the APA conducts a seventh area of research on its professionals. Finally, the study of under-resourced areas, such as HIV/AIDS training, comprises the eighth research area.

About the Author: With more than 20 years of experience in psychiatry, Thomas Gazda maintains membership in the American Psychiatric Association. Dr. Gazda has special expertise in the treatment of anxiety disorders, as well as affective and psychotic disorders. Dr. Thomas Gazda currently serves as a Psychiatric Consultant at Banner Desert Hospital in Mesa, Arizona, and as a Staff Psychiatrist at Banner Behavioral Health Hospital in Scottsdale.